Blueprint Medicines Corporation Stock News

Amalgamated Bank increased its position in Blueprint Medicines Corp (NASDAQ:BPMC) by 5.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i

Blueprint Medicines Corp (NASDAQ:BPMC) shares traded up 14.9% during trading on Tuesday . The stock traded as high as $59.00 and last traded at $58.95, 668,014 shares traded hands during mid-day tradi

Blueprint achieved positive results from phase 2 study using avapritinib to treat patients with indolent systemic mastocytosis; Part 2 of study using 25 mg QD t

Blueprint Medicines added to Best Ideas List at Wedbush Wedbush BPMC

BidaskClub upgraded shares of Blueprint Medicines (NASDAQ:BPMC) from a sell rating to a hold rating in a research note published on Thursday morning, BidAskClub reports. A number of other equities ana

Blueprint Medicines Corp (NASDAQ:BPMC) has earned an average rating of “Buy” from the sixteen analysts that are currently covering the company, Marketbeat reports. One research analyst has rated t

There have been multiple catalysts related to lead asset, avapritinib in 2020. The company also has other promising assets in its pipeline. Investors should con

Mar 20, 2020 (The Expresswire) -- Global “Gastrointestinal Stromal Tumor (GIST) Drug Market” Report 2020 is a comprehensive, professional report provides a...